PEOPLE - Calypte Biomedical makes appointment:
This article was originally published in Clinica
Nancy Katz has been appointed president, chief operating officer and board director of Calypte Biomedical. Ms Katz was most recently with Johnson and Johnson's diabetes testing division, Lifescan. In addition, David Collins becomes CEO, succeeding Bill Boeger who will continue as chairman. Calypte is a US manufacturer of urine-based HIV-1 tests.
You may also be interested in...
As the first emergency use authorization is granted, Pfizer and Moderna stand accused of neglecting poorer nations as wealthy countries snap up early access to COVID-19 vaccines.
Tensions between industry and the European Commission on the issue of health claims for botanical food supplements were aired on the second day of the BAH's High Level Conference on the Future of Medicines, with the EC saying the EU Green Deal is now higher up on its list of priorities for the foreseeable future.
Issues over supply and the use of a skinny label have the potential to take a toll on the market for the fish oil drug icosapent ethyl, one analyst has claimed in the wake of Hikma’s recent generic launch.